Literature DB >> 6220812

Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I. Description of model systems.

B D Jaffee, H N Claman.   

Abstract

A model murine system of chronic graft-versus-host disease (GVHD) was explored to determine its suitability for studying scleroderma-like syndromes. The basic protocol was to inject lymphoid cell suspensions into irradiated semiallogeneic or allogeneic recipients which had been irradiated. Serial body weights, skin biopsies, and anti-nuclear antibodies were followed. Changes seen in the skin included increased collagen deposition, a mononuclear infiltrate deep in the dermis, loss of dermal fat, and "dropout" of skin appendages such as hair follicles. Body weight loss was a sensitive index of GVHD. Anti-nuclear antibodies occurred at times, but did not correlate with the tissue changes in the skin of mice undergoing GVHD. This chronic GVHD syndrome was produced across major and minor histocompatibility barriers. The most consistent findings were seen in BALB/c recipients of B10.D2 cells. These strains are nonreactive in unprimed mixed-leukocyte cultures. This combination represents primarily a GVH reaction against minor antigens where the HVG reaction is suppressed by irradiation. Some data suggest that the cutaneous changes may be reversible with time.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6220812     DOI: 10.1016/0008-8749(83)90001-1

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  37 in total

Review 1.  Animal models for scleroderma: an update.

Authors:  Yan Zhang; Anita C Gilliam
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

2.  Mouse Models of Skin Fibrosis.

Authors:  Aleix Rius Rigau; Markus Luber; Jörg H W Distler
Journal:  Methods Mol Biol       Date:  2021

3.  Inhibition of EGFR Tyrosine Kinase by Erlotinib Prevents Sclerodermatous Graft-Versus-Host Disease in a Mouse Model.

Authors:  Florence Morin; Niloufar Kavian; Wioleta Marut; Christiane Chéreau; Olivier Cerles; Philippe Grange; Bernard Weill; Carole Nicco; Frédéric Batteux
Journal:  J Invest Dermatol       Date:  2015-05-04       Impact factor: 8.551

4.  C5aR1 regulates T follicular helper differentiation and chronic graft-versus-host disease bronchiolitis obliterans.

Authors:  Divya A Verghese; Nicholas Chun; Katelyn Paz; Miguel Fribourg; Trent M Woodruff; Ryan Flynn; Yuan Hu; Huabao Xiong; Weijia Zhang; Zhengzi Yi; Jing Du; Bruce R Blazar; Peter S Heeger
Journal:  JCI Insight       Date:  2018-12-20

Review 5.  Pathogenesis of systemic sclerosis-current concept and emerging treatments.

Authors:  Masutaka Furue; Chikage Mitoma; Hiroki Mitoma; Gaku Tsuji; Takahito Chiba; Takeshi Nakahara; Hiroshi Uchi; Takafumi Kadono
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

6.  Mice engrafted with human fetal thymic tissue and hematopoietic stem cells develop pathology resembling chronic graft-versus-host disease.

Authors:  Jennifer L Lockridge; Ying Zhou; Yusof A Becker; Shidong Ma; Shannon C Kenney; Peiman Hematti; Christian M Capitini; William J Burlingham; Annette Gendron-Fitzpatrick; Jenny E Gumperz
Journal:  Biol Blood Marrow Transplant       Date:  2013-06-24       Impact factor: 5.742

7.  STAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine model.

Authors:  Vedran Radojcic; Maria A Pletneva; Hung-Rong Yen; Sanja Ivcevic; Angela Panoskaltsis-Mortari; Anita C Gilliam; Charles G Drake; Bruce R Blazar; Leo Luznik
Journal:  J Immunol       Date:  2009-12-07       Impact factor: 5.422

8.  Immunohistologic and ultrastructural study of the sclerotic skin in chronic graft-versus-host disease in man.

Authors:  A Janin-Mercier; A Devergie; D Van Cauwenberge; J H Saurat; M Bourges; C M Lapiere; E Gluckman
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

Review 9.  Murine models of chronic graft-versus-host disease: insights and unresolved issues.

Authors:  Yu-Waye Chu; Ronald E Gress
Journal:  Biol Blood Marrow Transplant       Date:  2008-02-13       Impact factor: 5.742

Review 10.  The immune pathogenesis of scleroderma: context is everything.

Authors:  Matthew B Greenblatt; Antonios O Aliprantis
Journal:  Curr Rheumatol Rep       Date:  2013-01       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.